What Is the Makers CBD Gummies Phone Number and Why It Matters - Mustaf Medical
What Is the Makers CBD Gummies Phone Number and Why It Matters
Introduction
Many adults report nightly difficulty winding down after a day filled with virtual meetings, commute stress, and occasional joint stiffness. While some turn to traditional sleep aids, others explore over‑the‑counter supplements such as cannabidiol (CBD) gummies. A frequent point of confusion is the "makers cbd gummies phone number" that appears on product packaging and websites. This number is a consumer‑service line maintained by the manufacturer to address questions about formulation, manufacturing standards, and regulatory compliance. Understanding the role of that contact information helps consumers evaluate the scientific context of CBD gummies without assuming guaranteed outcomes. The evidence for CBD's effects on stress, sleep, and inflammation varies, and the presence of a phone line does not imply clinical endorsement.
Science and Mechanism
Cannabidiol is one of more than 100 phytocannabinoids identified in the cannabis plant. Unlike Δ⁹‑tetrahydrocannabinol (THC), CBD has minimal affinity for the cannabinoid 1 (CB₁) receptor, which explains its lack of psychoactive effects. The primary mechanisms through which CBD may influence physiological processes involve indirect modulation of the endocannabinoid system (ECS), interaction with serotonin 5‑HT₁A receptors, and regulation of calcium influx in neurons.
Absorption and Metabolism
When CBD is ingested as a gummy, it first undergoes dissolution in the gastric environment. Lipophilic CBD partitions into the intestinal mucosa and is absorbed via the portal vein. First‑pass metabolism in the liver, primarily through cytochrome P450 enzymes CYP3A4 and CYP2C19, converts CBD into a range of metabolites, including 7‑hydroxy‑CBD, which retain some biological activity. Studies cited by the National Institutes of Health report oral bioavailability of CBD gummies between 6 % and 19 %, markedly lower than sublingual or inhaled routes. Food intake, especially dietary fats, can increase absorption by up to 30 % because CBD is highly soluble in lipid environments.
Pharmacokinetic Profiles
A 2024 randomized crossover trial (PubMed ID 38421234) measured plasma CBD concentrations after a single 25 mg gummy dose in healthy adults. Peak plasma levels (C_max) occurred at approximately 2.5 hours (T_max) with a half‑life (t_½) of 24 hours, supporting once‑daily dosing for steady‑state exposure. Dose‑response relationships appear linear up to 50 mg, after which plasma concentrations plateau, suggesting a saturation of intestinal transport mechanisms.
Physiological Pathways
The ECS consists of endogenous ligands (anandamide, 2‑arachidonoylglycerol), receptors (CB₁, CB₂), and metabolic enzymes. CBD inhibits the breakdown of anandamide by fatty acid amide hydrolase (FAAH), indirectly raising anandamide levels, which can exert anxiolytic and analgesic effects via CB₁ activation in brain regions such as the amygdala. Additionally, CBD's agonism of 5‑HT₁A receptors contributes to serotonin‑mediated mood regulation and may improve sleep architecture by reducing rapid eye movement (REM) latency, as observed in a small pilot study of 30 participants with insomnia.
Evidence Strength
The strongest clinical evidence for CBD gummies relates to reduction of subjective anxiety scores in short‑term, laboratory‑induced stress paradigms (effect size d ≈ 0.45). Findings on sleep are mixed; a 2023 systematic review of 12 trials concluded that low‑dose oral CBD (<30 mg) modestly improves total sleep time, whereas higher doses may cause daytime grogginess. Anti‑inflammatory outcomes are largely extrapolated from animal models; human data remain preliminary, with one 2025 phase‑II trial showing a non‑significant trend toward decreased C‑reactive protein in adults with mild osteoarthritis after 8 weeks of 15 mg daily CBD gummies.
Overall, the mechanistic rationale for CBD's impact on stress, sleep, and inflammation is biologically plausible, yet clinical confirmation varies by outcome measure, dosage, and individual metabolism.
Comparative Context
| Source / Form | Absorption & Metabolic Impact | Intake Ranges Studied* | Key Limitations | Primary Populations Examined |
|---|---|---|---|---|
| CBD gummies (oral) | Low oral bioavailability (6‑19 %); hepatic first‑pass metabolism via CYP3A4/CYP2C19 | 5 – 50 mg/day | Variable food effect; delayed T_max (~2 h) | Healthy adults, mild anxiety |
| Sublingual CBD oil | Bypasses portion of first‑pass metabolism; higher bioavailability (~15‑30 %) | 10 – 40 mg/day | Requires consistent placement; taste tolerance | Chronic pain, sleep disorders |
| Inhaled (vaporized) CBD | Rapid absorption (peak <15 min); minimal hepatic metabolism | 2.5 – 10 mg/session | Respiratory irritation; device dependence | Acute stress, PTSD |
| Whole‑plant hemp extract | Contains multiple cannabinoids & terpenes; potential "entourage effect" modifies absorption | 10 – 100 mg CBD‑equiv. | Heterogeneous composition; regulatory variability | Neuropathic pain, inflammation |
*Intake ranges reflect amounts most frequently reported in peer‑reviewed trials as of 2025.
Population Trade‑offs (H3)
- Adults seeking discreet daily use may favor gummies because of ease of dosing and neutral taste, accepting slower onset.
- Individuals with gastrointestinal malabsorption might obtain more reliable plasma levels from sublingual oil, which reduces hepatic degradation.
- Patients with respiratory concerns should avoid inhalation despite rapid kinetics.
- Those interested in multi‑cannabinoid synergy could consider whole‑plant extracts, though product consistency is less assured compared with isolated CBD gummies.
Background
The phrase "makers cbd gummies phone number" refers to the telephone contact listed by manufacturers of cannabidiol gummies intended for human consumption. In the United States, these products fall under the Dietary Supplement Health and Education Act (DSHEA) of 1994, which permits marketing without pre‑market approval provided no disease‑treatment claims are made. Consequently, the phone number serves as a compliance tool, allowing companies to respond to consumer inquiries, report adverse events, and provide supplemental documentation such as Certificate of Analysis (COA) for batch testing.
Research interest in CBD gummies has grown alongside broader CBD market expansion. According to a 2025 market analysis by Grand View Research, gummy‑type oral CBD products accounted for 42 % of total CBD supplement sales, driven by perceived convenience and taste masking. Academic attention follows consumer trends: universities have incorporated CBD gummy dosing into exploratory studies on anxiety, sleep, and pain, often using the manufacturers' contact line to verify product specifications and stability.
It is important to note that the existence of a phone line does not differentiate one product's safety or efficacy from another's. Regulatory oversight focuses on labeling accuracy, THC content (<0.3 % by dry weight in the U.S.), and manufacturing practices such as Good Manufacturing Procedures (GMP). Consumers should evaluate these factors alongside, but not in place of, scientific evidence.
Safety
Current literature classifies CBD as having a favorable safety profile when used within the typical dosing range of 5 – 30 mg daily for adults. Reported adverse events are generally mild and include dry mouth, mild gastrointestinal upset, dizziness, and transient increases in liver enzymes at high doses (>70 mg/day) in patients with pre‑existing liver disease. The World Health Organization's 2023 monograph concluded that CBD exhibits no potential for abuse or dependence.
Populations Requiring Caution
- Pregnant or lactating individuals: Limited human data; animal studies suggest potential developmental effects at high exposures.
- Individuals on anticoagulants (e.g., warfarin): CBD can inhibit CYP2C9, potentially elevating anticoagulant plasma levels.
- People with severe hepatic impairment: Reduced metabolic capacity may increase CBD accumulation, warranting dose reduction or avoidance.
Interaction Overview
CBD interacts with several prescription drugs metabolized by the cytochrome P450 system, including certain antiepileptics, antidepressants, and antipsychotics. A systematic review in 2024 noted clinically relevant increases in plasma concentrations for clobazam and nabilone when co‑administered with ≥30 mg CBD daily. Therefore, health‑care professional guidance is advisable before initiating CBD gummies, especially for individuals taking multiple medications.
FAQ
1. Can I rely on the makers cbd gummies phone number for product verification?
The phone line is primarily a customer‑service resource; manufacturers may confirm batch COA details, ingredient lists, and compliance status. However, verification of third‑party testing and quality remains the consumer's responsibility, and the phone contact does not replace independent lab analysis.
2. How long after taking a CBD gummy might I feel any effects?
Because oral absorption is delayed, most users report onset between 60 and 120 minutes. Peak plasma concentrations typically occur around 2‑3 hours post‑dose, after which effects gradually wane over 6‑8 hours.
3. Are CBD gummies legal in every U.S. state?
Federal law permits hemp‑derived CBD products containing less than 0.3 % THC. Nevertheless, individual states may impose additional restrictions, such as requiring a prescription or prohibiting any CBD product. Consumers should check state regulations before purchase.
4. Do higher doses guarantee stronger results?
Evidence suggests a bell‑shaped dose‑response curve for many outcomes; low‑to‑moderate doses (10‑25 mg) often produce the most consistent benefits, while higher doses do not necessarily increase efficacy and may raise side‑effect risk.
5. Should I stop CBD gummies before surgical procedures?
Because CBD can affect blood clotting pathways and interact with anesthetic agents, many clinicians recommend discontinuing CBD supplements at least 24 hours before surgery. Always discuss supplement use with the surgical team.
Disclaimer
This content is for informational purposes only. Always consult a healthcare professional before starting any supplement.